Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: | Completed |
---|---|
Conditions: | Colitis, Colitis, Gastrointestinal |
Therapuetic Areas: | Gastroenterology |
Healthy: | No |
Age Range: | 18 - 80 |
Updated: | 1/30/2019 |
Start Date: | November 2015 |
End Date: | November 28, 2018 |
The purpose of this study is to determine whether etrasimod (APD334) is a safe and effective
treatment for ulcerative colitis after 52 weeks of treatment.
treatment for ulcerative colitis after 52 weeks of treatment.
Inclusion Criteria:
- Patients who completed the APD334-003 study
Exclusion Criteria:
- Patients who did not complete the APD334-003 study
We found this trial at
32
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials